INTERNATIONAL & USA PRESS INQUIRIES
Please contact David Fraser for international media inquiries
Please contact Corey Henry for USA media inquiries
May 24, 2019
Philip Morris International Inc. (PMI) Update on Its Medicago Inc. Holding
Under this agreement, both PM Investments and MTPC agreed to:
(i) cooperate with respect to the privatization of Medicago;
(ii) provide, on a pro rata basis, funds to effect the proposed privatization;
(iii) certain governance arrangements if the proposed privatization is completed; and
(iv) not pursue an acquisition of Medicago, other than pursuant to the Funding and Cooperation Agreement, during the term of the Funding and Cooperation Agreement.
The Funding and Cooperation agreement is terminable on the earliest of
the closing of the proposed privatization, by mutual agreement in
writing of both PM Investments and MTPC but at the latest on
PM Investments currently holds 98,608,800 common shares representing 38.5% of all of the issued and outstanding common shares of Medicago, when calculated on a non-fully diluted basis.
MTPC advised PM Investments that it is the beneficial owner of 15,385,000 common shares of Medicago, which represents 6.0% of all of the issued and outstanding common shares of Medicago, when calculated on a non-fully diluted basis.
After the privatization, Medicago will be owned 40% by PM Investments and 60% by MTPC.
Each common share of Medicago entitles the holder thereof to one vote. Accordingly, in the aggregate, PM Investments and MTPC beneficially own 113,993,800 common shares of Medicago, representing 44.5% of the votes attaching to the issued common shares of Medicago in the aggregate.
This news release is not an admission that MTPC and its affiliates own or control any described security or is a joint actor with PM Investments or any of its affiliates.
Philip Morris International Inc.
New York: +1 (917) 663 2233
Lausanne: +41 (0)58 242 4666
Lausanne: +41 (0)58 242 4500